Summary
The product THELOBSTER BPC-157, manufactured by THELOBSTER, underwent independent testing to verify its authenticity and potency. The sample, identified as batch LOB1, was submitted by THELOBSTER and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of BPC-157, with concentrations of 10.69 mg and 9.84 mg per vial. The product’s purity was determined to be 99.684% and 99.685%.
The testing process began on 29 April 2024, with the sample received on 7 May 2024, and analysis completed on 10 May 2024. The results confirm exceptional purity and accurate dosing, but scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: THELOBSTER
- Product Name: THELOBSTER BPC-157
- Active Ingredient: BPC-157
- Batch Number: LOB1
- Expiration Date: Not provided
- Delivery Method: Viral Powder
Sample Acquisition and Testing
- Task Number: #41964
- Testing Ordered: 29 April 2024
- Sample Received: 7 May 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: THELOBSTER
- Analysis Paid For By: THELOBSTER
Testing Results
- Measured Concentration: 10.69 mg; 9.84 mg
- Purity: 99.684%; 99.685%
Verification Details
Verification URL: https://janoshik.com/tests/41964_Q5PY9EAZWFT1
Evaluation of Manufacturer-Submitted Testing
This analysis highlights that THELOBSTER BPC-157 contains BPC-157 at an exceptionally high purity level of 99.684% and 99.685%, with measured concentrations of 10.69 mg and 9.84 mg per vial. The findings indicate a well-formulated and pure peptide product. However, since the test was submitted and funded by THELOBSTER, careful evaluation is necessary to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that THELOBSTER BPC-157 exhibits exceptional purity (99.684% and 99.685%) and accurate dosing (10.69 mg and 9.84 mg per vial). This batch demonstrates high manufacturing quality, but independent third-party testing is encouraged to validate consistency across different batches. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical and peptide products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
